Loading…
avatar for Thomas VanCott, Ph.D.

Thomas VanCott, Ph.D.

Catalent Cell and Gene Therapy
VP and Global Head of Product Development
Dr. VanCott joined Catalent through its acquisition of Paragon Gene Therapy in 2019. Prior to Paragon he spent 14 years as the President and CEO of Advanced Bioscience Laboratories Inc. (ABL), and previously held several positions at the Henry M. Jackson Foundation for the Advancement of Military Medicine. Dr. VanCott received a doctorate in physical chemistry from the University of Virginia, and a bachelor’s degree in chemistry from Dickinson College, Carlisle, Pennsylvania. 
  • Timezone
  • Filter By Type
  • Executive Interview
  • Keynote
  • Networking Break
  • Panel Session
  • Virtual Happy Hour